ImmunityBio, Inc. (IBRX)
Market Closed
16 Oct, 08:00 PM
$
9. 18
-0.82
-8.2%
$
9.73B Market Cap
- P/E Ratio
- Div Yield
21.48M Volume
-0.93 Eps
$ 10
Previous Close 
Want to track IBRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
ImmunityBio, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| PAM Parvin Asset Management LLC Parvin Asset Management LLC | 40,000 | $306,800 | $371,200 | $64,400 | 20.99% |
| GFM GF Fund Management Co. Ltd. GF Fund Management Co. Ltd. | 21,749 | $71,002.08 | $206,071.77 | $135,069.69 | 190.23% |
| JCB John Ciaran Burns Universal-Beteiligungs- und Servicegesellschaft mbH | 24,629 | $191,861.28 | $246,290 | $54,428.72 | 28.37% |
 David R. Hess Wealth Management Associates Inc. | 69,325 | $432,970.83 | $649,921.87 | $216,951.04 | 50.11% |
 HFM Investment Advisors LLC HFM Investment Advisors LLC | 28 | $246 | $279.24 | $33.24 | 13.51% |
| AS Aryn Sands GK Wealth Management LLC | 1,541 | $13,021.45 | $15,101.8 | $2,080.35 | 15.98% |
 Torrey Growth & Income Advisors Torrey Growth & Income Advisors | 118,860 | $952,607.3 | $1.18M | $227,672.5 | 23.9% |
2026 © Marketlog. All Rights Reserved.
